文献速递冠心病血脂与心血管预防

48万成人冠状动脉疾病的基因组风险预测:对一级预防的意义

Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

结果显示metaGRS每增加1个标准差,CAD风险比(HR)为1.71(95%CI:1.68-1.73),最高20%比最低20%的HR为4.17(95%CI:3.97-4.38),且C指数高于6种传统危险因素,提示基因组筛查可补充传统风险预测。

要点

  • metaGRS每升高1个标准差,CAD的HR为1.71(95%CI:1.68-1.73)。
  • 最高20%比最低20%的HR为4.17(95%CI:3.97-4.38)。
  • metaGRS的C指数为0.623(95%CI:0.615-0.631),高于6种传统因素。

核心结论

  • metaGRS可显著分层CAD风险轨迹,并可能作为早期基因组筛查工具补充传统风险预测。

研究设计与样本

  • 在UK Biobank的22,242例CAD病例和460,387例非病例中外部测试metaGRS单独及联合传统风险因素的表现。

主要发现

  • metaGRS每增加1个标准差,CAD的HR为1.71(95%CI:1.68-1.73)。
  • metaGRS最高20%比最低20%的HR为4.17(95%CI:3.97-4.38);在服用降脂或降压药物者中对应HR为2.83(95%CI:2.61-3.07)。
  • metaGRS对 incident CAD 的C指数为0.623(95%CI:0.615-0.631),高于吸烟、糖尿病、高血压、体重指数、自报高胆固醇和家族史6种传统因素。
  • metaGRS最高20%且具有>2个传统因素的男性,累积CAD风险在48岁时达到10%。

临床怎么用

  • 可考虑在早期生命阶段使用metaGRS筛查,以补充传统风险预测进行CAD一级预防。
  • 对于metaGRS高风险且合并多个传统危险因素的个体,可能需要更早启动预防干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronary artery disease (CAD) has substantial heritability and a polygenic architecture. However, the potential of genomic risk scores to help predict CAD outcomes has not been evaluated comprehensively, because available studies have involved limited genomic scope and limited sample sizes. OBJECTIVES: This study sought to construct a genomic risk score for CAD and to estimate its potential as a screening tool for primary prevention. METHODS: Using a meta-analytic approach to combine large-scale, genome-wide, and targeted genetic association data, we developed a new genomic risk score for CAD (metaGRS) consisting of 1.7 million genetic variants. We externally tested metaGRS, both by itself and in combination with available data on conventional risk factors, in 22,242 CAD cases and 460,387 noncases from the UK Biobank. RESULTS: The hazard ratio (HR) for CAD was 1.71 (95% confidence interval [CI]: 1.68 to 1.73) per SD increase in metaGRS, an association larger than any other externally tested genetic risk score previously published. The metaGRS stratified individuals into significantly different life course trajectories of CAD risk, with those in the top 20% of metaGRS distribution having an HR of 4.17 (95% CI: 3.97 to 4.38) compared with those in the bottom 20%. The corresponding HR was 2.83 (95% CI: 2.61 to 3.07) among individuals on lipid-lowering or antihypertensive medications. The metaGRS had a higher C-index (C = 0.623; 95% CI: 0.615 to 0.631) for incident CAD than any of 6 conventional factors (smoking, diabetes, hypertension, body mass index, self-reported high cholesterol, and family history). For men in the top 20% of metaGRS with >2 conventional factors, 10% cumulative risk of CAD was reached by 48 years of age. CONCLUSIONS: The genomic score developed and evaluated here substantially advances the concept of using genomic information to stratify individuals with different trajectories of CAD risk and highlights the potential for genomic screening in early life to complement conventional risk prediction.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Inouye M, Abraham G, Nelson CP, et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention. J Am Coll Cardiol. 2018. PMID: 30309464. doi:10.1016/j.jacc.2018.07.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。